FIBROGEN, INC.

FGEN

Real-time Estimate - 11/25 11:57:49 am
40.635USD	-1.68%

Prev.	41.3300
Open	41.3300
High	41.4000
Low	40.7200
Volume	38 913

11/12	FIBROGEN INC : Entry into a Material Definitive Agreement (form 8-K)
11/09	FibroGen : to Present at Upcoming Investor Conferences
11/06	FibroGen : to Present at Upcoming Investor Conferences
11/06	FibroGen to Present at Upcoming Investor Conferences

	Short Term	Mid-Term	Long Term
Trend	Neutral	Neutral	Bullish
Resistance	45,6	49,0	48,8
Spread/Res.	-11%	-17%	-17%
Spread/Supp.	6,2%	25%	16%
Support	38,4	32,6	35,0

Sales 2020	231 M - -
Net income 2020	-147 M - -
Net Debt 2020	- - -
P/E ratio 2020	-26,2x
Yield 2020	-

Capitalization	3 761 M 3 761 M -
Capi. / Sales 2020	16,3x
Capi. / Sales 2021	7,67x
Nbr of Employees	531
Free-Float	91,7%

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines...

>> Read more

Sector :

Biotechnology & Medical Research - NEC

Calendar :

2021-03-03 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	9
Average target price	62,13 $
Last Close Price	41,33 $
Spread / Highest target	123%
Spread / Average Target	50,3%
Spread / Lowest Target	6,46%